FHD-286
CAS No. 2671128-05-3
FHD-286( —— )
Catalog No. M28880 CAS No. 2671128-05-3
FHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 359 | In Stock |
|
| 5MG | 282 | In Stock |
|
| 10MG | 454 | In Stock |
|
| 25MG | 616 | In Stock |
|
| 50MG | 760 | In Stock |
|
| 100MG | 1042 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFHD-286
-
NoteResearch use only, not for human use.
-
Brief DescriptionFHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.
-
DescriptionFHD-286 is an inhibitor of BRM/BRG1 ATPase and can be used for studies on the treatment of BAF-related disorders such as acute myeloid leukemia.
-
In Vitro——
-
In VivoAnimal Model:B16F10 tumor-bearing miceDosage:1.5 mg/kg Administration:Oral administration; for 10 days Result:Increased in IFNγ and Th1-type chemokine CXCL10 levels.
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2671128-05-3
-
Formula Weight562.66
-
Molecular FormulaC24H30N6O6S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (444.32 mM)
-
SMILESC[C@H](C1)O[C@@H](C)CN1c1cccc(-c2csc(NC([C@H](COC)NC(c(cc3)cn3S(C)(=O)=O)=O)=O)n2)n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Qiao J, et al. Identification of a Novel Specific Cucurbitadienol Synthase Allele in Siraitia grosvenorii Correlates with High Catalytic Efficiency. Molecules. 2019 Feb 11;24(3).
molnova catalog
related products
-
JWG-071
JWG-071, the first reported chemical probe for ERK5 kinase selectivity, is a BET-selective inhibitor with a 1 μM BRD4 IC that enhances both ERK5 activity and BRD4 selectivity.
-
NEO2734
NEO2734 is an orally active and selective inhibitor of p300/CBP and BET bromodomain(IC50 of <30 nM for both p300/CBP and BET bromodomains).
-
DC-BPi-03
DC-BPi-03 is a potent BPTF-BRD inhibitor, exhibiting an IC50 of 698.3 nM and a Kd of 2.81 μM.
Cart
sales@molnova.com